Top Markets
Coin of the day
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Rankning i aktier #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
Aktiekurs
$0.00162013
Senast synkroniserad: 2025-01-03
Marknadsvärde
$156.25K
Förändring (1 dag)
0.36%
Förändring (1 år)
0.00%
Land
SE
Handel Cyxone AB (publ) (CYXO)

Kategori

Historik för aktiesplit för Cyxone AB (publ) (CYXO)
Aktien Cyxone AB (publ) (symbol: CYXO) har genomgått totalt 2 aktiesplitar.
Den senaste spliten skedde den Dec 28, 2021.
En CYXO-aktie köpt före Oct 03, 2018 motsvarar nu 1.12682 CYXO-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2021-12-28 103:100 x1.03 x1.12682
2018-10-03 547:500 x1.094 x1.094
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE